Cargando…
An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
As with many cancer treatments, tumor treating fields (TTFields) target rapidly dividing tumor cells. During mitosis, TTFields-exposed cells exhibit uncontrolled membrane blebbing at the onset of anaphase, resulting in aberrant mitotic exit. Based on these criteria, at least two protein complexes ha...
Autores principales: | Swanson, Kenneth D., Lok, Edwin, Wong, Eric T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703612/ https://www.ncbi.nlm.nih.gov/pubmed/26739692 http://dx.doi.org/10.1007/s11910-015-0606-5 |
Ejemplares similares
-
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
por: Chinot, Olivier L., et al.
Publicado: (2013) -
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
por: Wong, Eric T, et al.
Publicado: (2015) -
Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma
por: Wong, Eric T, et al.
Publicado: (2014) -
Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation
por: Wong, Eric T, et al.
Publicado: (2015) -
The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system
por: Turner, Scott G, et al.
Publicado: (2014)